AstraZeneca

Results: 2272



#Item
11Community Support Contributions: 2014 AstraZeneca Canada is proud to provide support to many different charitable and non-profit organizations across Canada. In 2014, we invested almost $6 million in health initiatives w

Community Support Contributions: 2014 AstraZeneca Canada is proud to provide support to many different charitable and non-profit organizations across Canada. In 2014, we invested almost $6 million in health initiatives w

Add to Reading List

Source URL: www.astrazeneca.ca

Language: English - Date: 2017-11-11 05:51:44
    12Community Support Contributions: 2012 AstraZeneca Canada is proud to provide support to many different charitable and non-profit organizations across Canada. In 2012, we invested almost $16 million in health initiatives

    Community Support Contributions: 2012 AstraZeneca Canada is proud to provide support to many different charitable and non-profit organizations across Canada. In 2012, we invested almost $16 million in health initiatives

    Add to Reading List

    Source URL: www.astrazeneca.ca

    Language: English - Date: 2017-11-16 21:16:49
      13PRESS RELEASE Gothenburg 17th of January 2018, 16:15 CELLINK establishes R&D lab in AstraZeneca’s BioVentureHub New lab to specialize in oncology research, as well as bioprinted lung and heart tissue models

      PRESS RELEASE Gothenburg 17th of January 2018, 16:15 CELLINK establishes R&D lab in AstraZeneca’s BioVentureHub New lab to specialize in oncology research, as well as bioprinted lung and heart tissue models

      Add to Reading List

      Source URL: mb.cision.com

      Language: English - Date: 2018-01-17 10:38:43
        14Growth factor GPCR Ligand

        Growth factor GPCR Ligand

        Add to Reading List

        Source URL: www.astrazeneca.com

        - Date: 2017-11-07 12:40:23
          15LUPUS PATIENTS EXPERIENCE INADEQUATE SYMPTOM CONTROL DESPITE TREATMENT1 Despite recent therapeutic advances improving patient outcomes, many patients still face: 1

          LUPUS PATIENTS EXPERIENCE INADEQUATE SYMPTOM CONTROL DESPITE TREATMENT1 Despite recent therapeutic advances improving patient outcomes, many patients still face: 1

          Add to Reading List

          Source URL: www.astrazeneca.com

          Language: English - Date: 2017-11-08 12:53:23
            16

            CTEP Non-clinical Study Proposal (Not for AstraZeneca or Arqule Requests)

            Add to Reading List

            Source URL: ctep.cancer.gov

            Language: English - Date: 2018-04-25 11:12:49
              17MYTH Only affects women versus REALITY in LUPUS

              MYTH Only affects women versus REALITY in LUPUS

              Add to Reading List

              Source URL: www.astrazeneca.com

              Language: English - Date: 2017-11-07 12:42:20
                18Community Support Contributions: 2013 AstraZeneca Canada is proud to provide support to many different charitable and non-profit organizations across Canada. In 2013, we invested more than $6 million in health initiative

                Community Support Contributions: 2013 AstraZeneca Canada is proud to provide support to many different charitable and non-profit organizations across Canada. In 2013, we invested more than $6 million in health initiative

                Add to Reading List

                Source URL: www.astrazeneca.ca

                Language: English - Date: 2017-11-11 05:52:14
                  19SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) CAN CAUSE PERMANENT CUMULATIVE ORGAN DAMAGE1,2 More than half of SLE patients develop permanent organ system damage which could lead to increased morbidity and mortality1,3 Damage is m

                  SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) CAN CAUSE PERMANENT CUMULATIVE ORGAN DAMAGE1,2 More than half of SLE patients develop permanent organ system damage which could lead to increased morbidity and mortality1,3 Damage is m

                  Add to Reading List

                  Source URL: www.astrazeneca.com

                  Language: English - Date: 2017-11-07 20:52:46
                    20

                    PDF Document

                    Add to Reading List

                    Source URL: www.astrazeneca.com

                    - Date: 2017-11-07 22:42:49